[1] |
Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations[J]. Am J Surg Pathol, 2013,37(5):676⁃684. doi: 10.1097/PAS.0b013e3182753de6.
|
[2] |
Abásolo A, Vargas MT, Ríos⁃Martín JJ, et al. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax⁃embedded tissues and imprint⁃cytology specimens[J]. Clin Exp Dermatol, 2012,37(8):838⁃843. doi: 10.1111/j.1365⁃2230.2012.04416.x.
|
[3] |
苏静, 柳剑英, 郑杰, 等. 多基因组合荧光原位杂交在皮肤恶性黑色素瘤辅助诊断中的应用[J]. 中华病理学杂志, 2015,44(1):37⁃41. doi: 10.3760/cma.j.issn.0529⁃5807.2015.01.008.
|
[4] |
Su J, Yu W, Liu J, et al. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases[J]. Pathology, 2017,49(7):740⁃749. doi: 10.1016/j.pathol. 2017.08.006.
|
[5] |
Muhlbauer A, Momtahen S, Mihm MC, et al. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential[J]. Ann Diagn Pathol, 2017,28:30⁃36. doi: 10.1016/j.anndiagpath.2016.11.001.
|
[6] |
Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms[J]. Am J Surg Pathol, 2012,36(6):808⁃817. doi: 10.1097/PAS.0b013e31824b1efd.
|
[7] |
Kumar CM, Sathisha UV, Dharmesh S, et al. Interaction of sesamol (3,4⁃methylenedioxyphenol) with tyrosinase and its effect on melanin synthesis[J]. Biochimie, 2011,93(3):562⁃569. doi: 10.1016/j.biochi.2010.11.014.
|
[8] |
Wang J, Lee TS, Zhang Z, et al. A bioluminogenic probe for monitoring tyrosinase activity[J]. Chem Asian J, 2017,12(4):397⁃400. doi: 10.1002/asia.201601659.
|
[9] |
Peng M, Wang Y, Fu Q, et al. Melanosome⁃targeting near⁃infrared fluorescent probe with large stokes shift for in situ quantification of tyrosinase activity and assessing drug effects on differently invasive melanoma cells[J]. Anal Chem, 2018,90(10):6206⁃6213. doi: 10.1021/acs.analchem.8b00734.
|
[10] |
Li Z, Wang YF, Zeng C, et al. Ultrasensitive tyrosinase⁃activated turn⁃on near⁃infrared fluorescent probe with a rationally designed urea bond for selective imaging and photodamage to melanoma cells[J]. Anal Chem, 2018,90(6):3666⁃3669. doi: 10.1021/acs.analchem.7b05369.
|
[11] |
Li H, Liu W, Zhang F, et al. Highly selective fluorescent probe based on hydroxylation of phenylboronic acid pinacol ester for detection of tyrosinase in cells[J]. Anal Chem, 2018,90(1):855⁃858. doi: 10.1021/acs.analchem.7b03681.
|
[12] |
Sweeny L, Prince A, Patel N, et al. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies[J]. Laryngoscope, 2016,126(12):E387⁃E395. doi: 10.1002/lary.26215.
|
[13] |
Scala S. Molecular pathways: targeting the CXCR4⁃CXCL12 axis⁃⁃untapped potential in the tumor microenvironment[J]. Clin Cancer Res, 2015,21(19):4278⁃4285. doi: 10.1158/1078⁃0432.CCR⁃14⁃0914.
|
[14] |
Santagata S, Portella L, Napolitano M, et al. A novel CXCR4⁃targeted near⁃infrared (NIR) fluorescent probe (Peptide R⁃NIR750) specifically detects CXCR4 expressing tumors[J]. Sci Rep, 2017,7(1):2554. doi: 10.1038/s41598⁃017⁃02818⁃6.
|
[15] |
Mikula H, Stapleton S, Kohler RH, et al. Design and development of fluorescent vemurafenib analogs for in vivo imaging[J]. Theranostics, 2017,7(5):1257⁃1265. doi: 10.7150/thno.18238.
|
[16] |
Knackstedt RW, Couto RA, Gastman B. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma[J]. J Surg Res, 2018,228:77⁃83. doi: 10.1016/j.jss.2018.02.064.
|
[17] |
Göppner D, Nekwasil S, Jellestad A, et al. Indocyanine green⁃assisted sentinel lymph node biopsy in melanoma using the "FOVIS" system[J]. J Dtsch Dermatol Ges, 2017,15(2):169⁃178. doi: 10.1111/ddg.12794.
|
[18] |
Vahabzadeh⁃Hagh AM, Blackwell KE, Abemayor E, et al. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system[J]. Am J Otolaryngol, 2018,39(5):485⁃488. doi: 10.1016/j.amjoto.2018. 05.006.
|
[19] |
Borbón⁃Arce M, Brouwer OR, van den Berg NS, et al. An innovative multimodality approach for sentinel node mapping and biopsy in head and neck malignancies[J]. Rev Esp Med Nucl Imagen Mol, 2014,33(5):274⁃279. doi: 10.1016/j.remn. 2013.11.005.
|
[20] |
Korn JM, Tellez⁃Diaz A, Bartz⁃Kurycki M, et al. Indocyanine green SPY elite⁃assisted sentinel lymph node biopsy in cutaneous melanoma[J]. Plast Reconstr Surg, 2014,133(4):914⁃922. doi: 10.1097/PRS.0000000000000006.
|
[21] |
Brouwer OR, Buckle T, Vermeeren L, et al. Comparing the hybrid fluorescent⁃radioactive tracer indocyanine green⁃99mTc⁃nanocolloid with 99mTc⁃nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT[J]. J Nucl Med, 2012,53(7):1034⁃1040. doi: 10.2967/ jnumed.112.103127.
|
[22] |
Knackstedt R, Couto RA, Ko J, et al. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in melanoma: increasing the sentinel lymph node⁃positive rate[J]. Ann Surg Oncol, 2019,26(11):3550⁃3560. doi: 10.1245/s10434⁃019⁃07617⁃z.
|
[23] |
Yang X, Wang Z, Zhang F, et al. Mapping sentinel lymph node metastasis by dual⁃probe optical imaging[J]. Theranostics, 2017,7(1):153⁃163. doi: 10.7150/thno.17085.
|
[24] |
KleinJan GH, Karakullukçu B, Klop W, et al. Introducing navigation during melanoma⁃related sentinel lymph node procedures in the head⁃and⁃neck region[J]. EJNMMI Res, 2017,7(1):65. doi: 10.1186/s13550⁃017⁃0312⁃1.
|